Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Mayo Clin Proc. 2013 Jun 19;88(7):697–707. doi: 10.1016/j.mayocp.2013.04.021

Table 1.

Age- and sex-specific prevalence (per 100 population) of the 20 most common drug groups in the 2009 Olmsted County, MN, population (N = 142,377)

Drug group Age (y)a
All ages
0-18
19-29
30-49
50-64
65+
Crudeb
Standardizedc %
No. % No. % No. % No. % No. % No. %
Penicillins and beta-lactam antimicrobials
 Both sexes 8,771 22.75 3,177 13.26 5,563 14.67 3,462 14.08 2,761 15.93 23,734 16.67 16.60
 Men (boys) 4,377 22.32 1,035 10.01 2,170 12.13 1,433 12.47 1,181 15.68 10,196 15.25 15.07
 Women (girls) 4,394 23.19 2,142 15.71 3,393 16.93 2,029 15.50 1,580 16.12 13,538 17.93 18.13
Antidepressants
 Both sexes 1,010 2.62 2,663 11.11 6,310 16.64 4,900 19.93 3,145 18.14 18,028 12.66 12.51
 Men (boys) 409 2.09 766 7.41 1,953 10.92 1,493 12.99 978 12.98 5,599 8.37 8.56
 Women (girls) 601 3.17 1,897 13.92 4,357 21.74 3,407 26.02 2,167 22.11 12,429 16.46 16.21
Opioid analgesics
 Both sexes 1,606 4.17 2,898 12.09 5,258 13.86 3,844 15.63 3,348 19.31 16,954 11.91 11.84
 Men (boys) 847 4.32 1,064 10.29 2,117 11.83 1,706 14.84 1,354 17.97 7,088 10.60 10.77
 Women (girls) 759 4.01 1,834 13.45 3,141 15.67 2,138 16.33 1,994 20.34 9,866 13.07 12.85
Antilipemic agents
 Both sexes 15 0.04 127 0.53 2,539 6.69 6,377 25.94 7,024 40.52 16,082 11.30 11.07
 Men (boys) 10 0.05 77 0.74 1,635 9.14 3,386 29.45 3,292 43.70 8,400 12.56 12.73
 Women (girls) 5 0.03 50 0.37 904 4.51 2,991 22.85 3,732 38.07 7,682 10.17 9.57
Vaccines/toxoids
 Both sexes 8,926 23.15 1,878 7.84 2,259 5.96 1,742 7.08 1,113 6.42 15,918 11.18 11.07
 Men (boys) 4,330 22.08 550 5.32 1,048 5.86 798 6.94 481 6.39 7,207 10.78 10.40
 Women (girls) 4,596 24.26 1,328 9.74 1,211 6.04 944 7.21 632 6.45 8,711 11.54 11.77
Anti-asthmatics
 Both sexes 3,921 10.17 1,697 7.08 3,520 9.28 2,477 10.07 2,080 12.00 13,695 9.62 9.56
 Men (boys) 2,138 10.90 538 5.20 1,208 6.75 827 7.19 819 10.87 5,530 8.27 8.22
 Women (girls) 1,783 9.41 1,159 8.50 2,312 11.54 1,650 12.60 1,261 12.86 8,165 10.81 10.83
Topical anti-infective/anti-inflammatory agents
 Both sexes 2,952 7.66 1,529 6.38 3,122 8.23 2,840 11.55 2,819 16.26 13,262 9.31 9.22
 Men (boys) 1,467 7.48 503 4.87 1,144 6.40 1,130 9.83 1,229 16.31 5,473 8.19 8.20
 Women (girls) 1,485 7.84 1,026 7.53 1,978 9.87 1,710 13.06 1,590 16.22 7,789 10.31 10.23
Erythromycins/macrolides
 Both sexes 3,364 8.72 1,843 7.69 3,963 10.45 2,385 9.70 1,507 8.69 13,062 9.17 9.13
 Men (boys) 1,653 8.43 513 4.96 1,360 7.60 906 7.88 598 7.94 5,030 7.52 7.51
 Women (girls) 1,711 9.03 1,330 9.76 2,603 12.99 1,479 11.30 909 9.27 8,032 10.64 10.71
Gastrointestinal medications, other
 Both sexes 395 1.02 998 4.16 3,074 8.11 3,321 13.51 3,253 18.76 11,041 7.75 7.70
 Men (boys) 184 0.94 373 3.61 1,319 7.37 1,370 11.92 1,276 16.94 4,522 6.76 6.92
 Women (girls) 211 1.11 625 4.59 1,755 8.76 1,951 14.90 1,977 20.17 6,519 8.63 8.39
Laxatives
 Both sexes 675 1.75 727 3.03 2,352 6.20 3,858 15.69 2,705 15.60 10,317 7.25 7.05
 Men (boys) 303 1.55 199 1.93 863 4.82 1,761 15.32 1,235 16.39 4,361 6.52 6.50
 Women (girls) 372 1.96 528 3.87 1,489 7.43 2,097 16.02 1,470 15.00 5,956 7.89 7.63
Beta-blockers and related medications
 Both sexes 77 0.20 235 0.98 1,357 3.58 3,201 13.02 5,229 30.16 10,099 7.09 6.97
 Men (boys) 34 0.17 76 0.74 633 3.54 1,717 14.94 2,420 32.13 4,880 7.30 7.45
 Women (girls) 43 0.23 159 1.17 724 3.61 1,484 11.34 2,809 28.65 5,219 6.91 6.59
ACE inhibitors
 Both sexes 30 0.08 112 0.47 1,455 3.84 3,418 13.90 4,740 27.34 9,755 6.85 6.75
 Men (boys) 19 0.10 75 0.73 879 4.91 1,920 16.70 2,190 29.07 5,083 7.60 7.73
 Women (girls) 11 0.06 37 0.27 576 2.87 1,498 11.44 2,550 26.01 4,672 6.19 5.87
Diuretics
 Both sexes 46 0.12 147 0.61 1,368 3.61 3,100 12.61 5,092 29.37 9,753 6.85 6.75
 Men (boys) 21 0.11 54 0.52 550 3.07 1,313 11.42 1,969 26.14 3,907 5.84 5.99
 Women (girls) 25 0.13 93 0.68 818 4.08 1,787 13.65 3,123 31.86 5,846 7.74 7.37
Topical nasal and throat agents
 Both sexes 1,419 3.68 1,088 4.54 2,766 7.29 2,202 8.96 1,635 9.43 9,110 6.40 6.37
 Men (boys) 822 4.19 381 3.69 1,090 6.09 909 7.91 702 9.32 3,904 5.84 5.88
 Women (girls) 597 3.15 707 5.19 1,676 8.36 1,293 9.88 933 9.52 5,206 6.89 6.84
Antihistamines
 Both sexes 2,013 5.22 1,330 5.55 2,655 7.00 1,919 7.80 1,117 6.44 9,034 6.35 6.28
 Men (boys) 1,092 5.57 395 3.82 876 4.90 614 5.34 404 5.36 3,381 5.06 5.04
 Women (girls) 921 4.86 935 6.86 1,779 8.88 1,305 9.97 713 7.27 5,653 7.49 7.45
Anti-rheumatics
 Both sexes 989 2.56 1,325 5.53 2,798 7.38 2,108 8.57 1,153 6.65 8,373 5.88 5.83
 Men (boys) 466 2.38 430 4.16 1,113 6.22 898 7.81 469 6.23 3,376 5.05 5.10
 Women (girls) 523 2.76 895 6.57 1,685 8.41 1,210 9.24 684 6.98 4,997 6.62 6.54
Sedatives/hypnotics
 Both sexes 205 0.53 969 4.04 2,816 7.42 2,282 9.28 1,635 9.43 7,907 5.55 5.53
 Men (boys) 93 0.47 308 2.98 1,059 5.92 885 7.70 611 8.11 2,956 4.42 4.54
 Women (girls) 112 0.59 661 4.85 1,757 8.77 1,397 10.67 1,024 10.45 4,951 6.56 6.45
Adrenal corticosteroids
 Both sexes 1,498 3.89 799 3.33 1,982 5.23 1,559 6.34 1,549 8.94 7,387 5.19 5.17
 Men (boys) 862 4.40 302 2.92 726 4.06 587 5.11 657 8.72 3,134 4.69 4.71
 Women (girls) 636 3.36 497 3.65 1,256 6.27 972 7.42 892 9.10 4,253 5.63 5.61
Quinolones
 Both sexes 191 0.50 969 4.04 2,009 5.30 1,899 7.72 2,272 13.11 7,340 5.16 5.08
 Men (boys) 63 0.32 237 2.29 662 3.70 736 6.40 863 11.46 2,561 3.83 3.94
 Women (girls) 128 0.68 732 5.37 1,347 6.72 1,163 8.88 1,409 14.37 4,779 6.33 6.15
Systemic contraceptives
 Both sexes 881 2.28 3,357 14.01 2,592 6.83 190 0.77 24 0.14 7,044 4.95 4.55
 Men (boys) 1 0.01 5 0.05 17 0.10 20 0.17 6 0.08 49 0.07 0.07
 Women (girls) 880 4.64 3,352 24.59 2,575 12.85 170 1.30 18 0.18 6,995 9.26 9.10
a

Numbers to the left of the prevalence figure indicate the actual number of cases observed. Prevalence can be computed by dividing the number of cases by the corresponding denominator listed below (and multiplying by 100)

Denominators for men (boys) and women (girls) combined: 0-18=38,558; 19-29=23,968; 30-49=37,927; 50-64=24,588; 65+=17,336

Denominators for men (boys): 0-18=19,611; 19-29=10,337; 30-49=17,888; 50-64=11,496; 65+=7533

Denominators for women (girls): 0-18=18,947; 19-29=13,631; 30-49=20,039; 50-64=13,092; 65+=9803

b

A crude prevalence was computed by dividing cases observed across all ages by the total population

c

Overall prevalence for men (boys) and women (girls) combined was standardized by age and sex; overall prevalence for men (boys) and women (girls) separately was standardized only by age (direct standardization using the 2000 US census population)